AN experimental drug from Eli Lilly works best if Alzheimer's patients are treated as early as possible, ideally before they develop symptoms of the brain-wasting disease, researchers said on Monday, in the latest promising development for treating the most common form of dementia.
The drug, donanemab, has been shown to slow progression of memory and thinking problems by about a third, but that rate doubles to 60% if the drug is started when patients are only mildly impaired, according to new trial data presented at the Alzheimer's Association International Conference in Amsterdam.
The full analysis from the study involving more than 1,700 patients showed that results were less robust for older, later-stage patients as well as those with higher levels of a protein called tau that has been linked to Alzheimer's disease progression.
The findings underscore that "earlier detection and diagnosis can really change the trajectory of this disease," said Anne White, president of neuroscience at Lilly.
Lilly expects the U.S. Food and Drug Administration to decide by the end of this year whether to approve donanemab. It said submissions to other global regulators are underway, and most will be completed by year end.
Donanemab, like the recently approved Leqembi from Eisai 4523.T and Biogen BIIB.O, is an intravenous antibody designed to remove deposits of a protein called beta amyloid from the brains of Alzheimer's patients.
Referring to Lilly's data released on Monday, Dr. Susan Kohlhaas, executive director of research & partnerships at Alzheimer's Research UK, said, "These results provide further confirmation that removing amyloid from the brain can change the course of Alzheimer's, and may help people affected by this devastating disease if they're treated at the right time."
SIDE EFFECTS
Lilly's study showed that brain swelling, a known side effect of amyloid-clearing antibodies, occurred in more than 40% of patients with a genetic predisposition to develop Alzheimer's.
The company had previously reported that 24% of the overall donanemab treatment group had brain swelling. Brain bleeding occurred in 31% of the donanemab group and about 14% of the placebo group.
The deaths of three trial patients were linked to the treatment, researchers reported.
"These side effects should not be taken lightly," but most cases were manageable by monitoring with magnetic resonance imaging (MRI) or stopping the drug, said study investigator Dr. Liana Apostolova, professor in Alzheimer's Disease research at Indiana University School of Medicine.
Doctors are likely to use "very stringent MRI safety screening while we treat these patients," she said.
Lilly said donanemab's treatment effect continued to increase relative to placebo over the course of the 18-month trial, even for participants who had been taken off the drug after their levels of amyloid deposits fell significantly.
"At the end of the trial, the average patient had been without drug for seven months and yet they continued to benefit," White said.
She said the findings support the idea that donanemab can be stopped once amyloid is cleared from the brain.
"Some patients did not worsen significantly during the trial and on average progression of disease was slowed 4.4-7.5 months over 18 months," said Dr. Liz Coulthard, associate professor in dementia neurology at the University of Bristol.
Lilly said in May that the study had met all of its goals, showing that donanemab slowed cognitive decline by 29% compared to a placebo in people with mild cognitive impairment or mild dementia whose brains had deposits of two key Alzheimer's proteins, beta amyloid and tau.
For high tau patients, donanemab was shown to slow disease progression by about 17%, while the benefit was 35% for those with low-to-intermediate tau levels.
The full study results were also published in JAMA.
"Whether the harms of these drugs are balanced by their modest clinical benefits will ultimately require more data," an editorial in JAMA alongside the study said.
The FDA this month granted standard approval to Leqembi, the first Alzheimer's disease-modifying treatment to achieve that goal, clearing the way for wider insurance coverage of the drug.
Both medications are also being studied in large trials to see if they have an impact on delaying onset of Alzheimer's disease symptoms.
The latest study "gives me great hope" for the outcomes of those prevention trials, said Dr. Reisa Sperling, who directs the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital in Boston.
More than 6 million Americans are living with Alzheimer's, according to the Alzheimer's Association. More than 55 million people worldwide have Alzheimer's or other forms of dementia, according to the U.N. World Health Organization.
Shares of Lilly, which reached an all-time high near $469 in June, were nearly unchanged at $449.98 in midday trading on the New York Stock Exchange.
Reuters
Tue Jul 18 2023
![Experimental drug works best for Alzheimer's patients treated as early as possible Experimental drug works best for Alzheimer's patients treated as early as possible](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-09/81663645476_demensia.jpg)
The drug, donanemab, has been shown to slow progression of memory and thinking problems by about a third, but that rate doubles to 60% if the drug is started when patients are only mildly impaired, according to new trial data presented. - UNSPLASH
Kim Pan-gon letak jawatan berikutan komitmen peribadi
Pengurus pasukan kebangsaan Malaysia, Kim Pan-gon menyatakan perletakan jawatan tersebut kerana komitmen peribadi.
#AWANInews
#AWANInews
![Penggunaan dron tingkat keberkesanan pemantauan pencemaran - Nik Nazmi Penggunaan dron tingkat keberkesanan pemantauan pencemaran - Nik Nazmi](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/71721102997_SimposiumDronKeban.jpg)
Penggunaan dron tingkat keberkesanan pemantauan pencemaran - Nik Nazmi
Penggunaan dron membolehkan pemantauan pencemaran alam sekitar dan hidupan liar serta pencerobohan hutan dilaksanakan dengan lebih berkesan.
![Kim Pan-gon letak jawatan ketua jurulatih Harimau Malaya Kim Pan-gon letak jawatan ketua jurulatih Harimau Malaya](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-06/71718142997_KimPanGon.jpg)
Kim Pan-gon letak jawatan ketua jurulatih Harimau Malaya
Kim Pan-gon, bakal menjadi satu-satunya individu yang bakal meninggalkan pasukan manakala Pau Marti bersama staf sokongan yang lain kekal di Kelana Jaya.
![Bekas pengawal peribadi Wan Azizah cedera kemalangan Bekas pengawal peribadi Wan Azizah cedera kemalangan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/51721109015_bekaspengawalperib.jpg)
Bekas pengawal peribadi Wan Azizah cedera kemalangan
Bekas anggota polis wanita yang kini bekerja sebagai pengawal peribadi cedera setelah motosikal ditunggangnya melanggar sebuah SUV di lebuh raya PLUS.
![Rang Undang-undang Kebebasan Maklumat dijangka dibentang akhir tahun ini - Kulasegaran Rang Undang-undang Kebebasan Maklumat dijangka dibentang akhir tahun ini - Kulasegaran](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81719996195_MKulasegaran.jpg)
Rang Undang-undang Kebebasan Maklumat dijangka dibentang akhir tahun ini - Kulasegaran
RUU Kebebasan Maklumat dijangka dibentangkan di Parlimen pada akhir tahun ini selepas cadangan ketetapan bagi penggubalan Akta Kebebasan Maklumat dibawa ke Jemaah Menteri untuk kelulusan.
![Azizi dilantik Ketua Polis Perak baharu Azizi dilantik Ketua Polis Perak baharu](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/51721108438_azizi.jpg)
Azizi dilantik Ketua Polis Perak baharu
Timbalan Ketua Polis Perak Datuk Azizi Mat Aris dilantik sebagai Ketua Polis Perak yang baharu hari ini.
![ADUN Rembia sertai Pas, tak 'lompat parti' - Takiyuddin ADUN Rembia sertai Pas, tak 'lompat parti' - Takiyuddin](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/51721108165_ADUNRembiaPN.jpg)
ADUN Rembia sertai Pas, tak 'lompat parti' - Takiyuddin
Menurut Takiyuddin, keahlian Muhamad Jailani yang juga wakil rakyat UMNO diterima pada 10 Jun tahun lalu, namun diumumkan secara rasmi hari ini.
Kita perlu belajar hidup dengan COVID-19 - Pakar
Itu kata Pakar Perubatan Kesihatan Awam, Bahagian Kawalan Penyakit, Kementerian Kesihatan Malaysia (KKM), Dr Aznida Mohamad Zaki yang berkata pihaknya akan berusaha semampu mungkin dalam menggalakkan praktis kendiri dikalangan orang awam bagi mencegah penularan wabak seperti mana yang pernah dilakukan sebelum ini.
LHDN lulus 141,406 permohonan PKPS 2.0
Lembaga Hasil Dalam Negeri (LHDN) telah meluluskan sebanyak 141,406 permohonan program khas pengakuan sukarela (PKPS) 2.0 yang melibatkan 102,572 bilangan kes pembayar cukai individu, 27,707 bilangan kes syarikat dan selebihnya melibatkan lain kategori seperti pertubuhan.
![Pelan Transformasi Air sasar tingkatkan air bersih, liputan sistem kumbahan - Fadillah Pelan Transformasi Air sasar tingkatkan air bersih, liputan sistem kumbahan - Fadillah](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-07/81721017239_TBFADILLAH.jpg)
Pelan Transformasi Air sasar tingkatkan air bersih, liputan sistem kumbahan - Fadillah
Pelan Transformasi Air sasar tingkatkan air bersih, tingkatkan liputan sistem kumbahan - Fadillah
![Berita antarabangsa pilihan sepanjang hari ini Berita antarabangsa pilihan sepanjang hari ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-04/41680607592_TBBERITAx.jpg)
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
![Tony Bennett meninggal dunia pada usia 96 tahun Tony Bennett meninggal dunia pada usia 96 tahun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-07/71689947195_TBTONYBENNET.jpg)
Tony Bennett meninggal dunia pada usia 96 tahun
Penyanyi pop dan jazz popular yang memenangi 20 Anugerah Grammy, Tony Bennett meninggal dunia pada usia 96 tahun di New York, pada Jumaat.
![FDA AS lulus ubat Leqembi untuk rawat Alzheimer FDA AS lulus ubat Leqembi untuk rawat Alzheimer](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2023-07/41688790542_LEQEMBIAlzheimer.jpg)
FDA AS lulus ubat Leqembi untuk rawat Alzheimer
Leqembi berfungsi dengan mengurangkan amyloid plaques yang terbentuk di dalam otak, menurut FDA.
![Pesakit Alzheimer di seluruh dunia mungkin cecah 139 juta menjelang 2050 - Laporan Pesakit Alzheimer di seluruh dunia mungkin cecah 139 juta menjelang 2050 - Laporan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-06/71623120622_ALZHEIMERS.jpg)
Pesakit Alzheimer di seluruh dunia mungkin cecah 139 juta menjelang 2050 - Laporan
Jumlah pesakit Alzheimer di dunia mungkin mencecah 139 juta menjelang 2050, menurut laporan terbaharu Pertubuhan Kesihatan Sedunia (WHO).
![Isteri hidap Alzheimer turut dijangkiti COVID-19, Engelbert Humperdinck mohon doa peminat Isteri hidap Alzheimer turut dijangkiti COVID-19, Engelbert Humperdinck mohon doa peminat](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-02/61612529082_EngelbertHumperdinc.jpg)
Isteri hidap Alzheimer turut dijangkiti COVID-19, Engelbert Humperdinck mohon doa peminat
Penyanyi balada terkenal Britain, Engelbert Humperdinck meminta peminat agar mendoakan kesihatan isterinya.
![Hari Alzheimer Sedunia: KKM bangunkan Pelan Tindakan Demensia 2021-2030 Hari Alzheimer Sedunia: KKM bangunkan Pelan Tindakan Demensia 2021-2030](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-09/41600679419_AlzheimerDemensia.jpg)
Hari Alzheimer Sedunia: KKM bangunkan Pelan Tindakan Demensia 2021-2030
Ketika ini KKM mengambil beberapa inisiatif dalam meningkatkan liputan rawatan dalam penjagaan geriatrik.
![Pesakit Alzheimer perlu penjagaan rapi Pesakit Alzheimer perlu penjagaan rapi](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-09/51600662334_AlzheimerDemensia.jpg)
Pesakit Alzheimer perlu penjagaan rapi
Dengan peningkatan populasi warga emas, sistem sokongan dalam masyarakat perlu dipertingkatkan bagi membantu ahli keluarga yang menjaga warga emas yang menghidap Alzheimer.
![Penghidap Alzheimer makin bertambah, Malaysia masih tiada Pelan Demensia Kebangsaan Penghidap Alzheimer makin bertambah, Malaysia masih tiada Pelan Demensia Kebangsaan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-09/71600663318_AlzheimerDementia.jpg)
Penghidap Alzheimer makin bertambah, Malaysia masih tiada Pelan Demensia Kebangsaan
Pelan Demensia Kebangsaan itu akan membantu 'generasi sandwich' iaitu golongan pertengahan usia yang mempunyai komitmen bukan sahaja membesarkan anak-anak tetapi juga menjaga ibu bapa mereka.
!['Kawanku', peranti bantu warga emas nyanyuk 'Kawanku', peranti bantu warga emas nyanyuk](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/http://img.astroawani.com/2018-12/71544252467_TBPROTOTAIPx.jpg)
'Kawanku', peranti bantu warga emas nyanyuk
'Kawanku' berpotensi membantu warga emas menjalani aktiviti harian melalui maklumat dan arahan audio secara automatik.
![Akibat ketagih, 'Pakcik Pokemon' luang 20 jam bawa 11 telefon keliling Taipei Akibat ketagih, 'Pakcik Pokemon' luang 20 jam bawa 11 telefon keliling Taipei](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/http://img.astroawani.com/2018-08/51533962910_TBPokemon.jpg)
Akibat ketagih, 'Pakcik Pokemon' luang 20 jam bawa 11 telefon keliling Taipei
Chen San-yuan, 70, mampu bermain Pokemon Go sehingga 20 jam tanpa henti menggunakan 11 telefon dan sembilan power bank yang dibawanya.